Archived Insight | April 12, 2022

Well-Funded Multiemployer Pension Plans Improved Benefits

Financially troubled multiemployer pension plans continue to be the focus of attention, particularly now that they may be eligible to apply for PBGC special financial assistance (SFA). Despite that understandable spotlight, it’s important to keep in mind that most plans are not in critical and declining status (i.e., facing insolvency).

In fact, many strong multiemployer pension plans have improved benefits over the past three years.

To see a snapshot of data from our latest survey, download an infographic.

Get the Infographic

Well-Funded Multiemployer Pension Plans Improved Benefits Download Now

Is your board considering making benefit improvements?

We can help you evaluate your plan’s financial health and the affordability of benefit improvements. Let's Talk.

Segal’s Winter 2022 Survey of Plans’ Zone Status

The 283 plans included in this survey are those with plan years that range from January 1 to July 1.

As a group, these plans have more than $215 billion in assets, provide benefits to just over 3.5 million participants and represent approximately one-third of all participants in multiemployer plans.

The 2021 zone-status certifications for the plans in the survey reflect investment performance before the current market volatility and geopolitical uncertainty.

 

See more insights

Female Nutritionist Holding Image Of Healthy Eating Plate

Health Coaching Enhances Well-Being and Productivity

Your organization can derive significant value from integrating health coaching into its existing health-management programs.
Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.
Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.